ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SGMT Sagiment Biosciences Inc

4.44
-0.13 (-2.84%)
May 10 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Sagiment Biosciences Inc SGMT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -2.84% 4.44 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.60 4.36 4.7277 4.44 4.57
more quote information »

Recent News

Date Time Source Heading
5/08/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/08/202416:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
5/06/202408:06EDGAR2Form 8-K - Current report
3/25/202407:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
3/25/202406:15GLOBESagimet Biosciences Reports Full Year 2023 Financial Results..
2/29/202408:00GLOBESagimet Biosciences to Participate in Two Upcoming Investor..
2/14/202418:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202416:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/05/202416:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/02/202416:36EDGAR2Form 8-K - Current report
2/02/202416:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/31/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202416:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202416:05EDGAR2Form 8-K - Current report
1/26/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/25/202420:58GLOBESagimet Biosciences Announces Pricing of Public Offering of..
1/24/202406:10EDGAR2Form 8-K - Current report
1/24/202406:08EDGAR2Form S-1/A - General form for registration of securities..
1/23/202417:45GLOBESagimet Biosciences Announces Proposed Public Offering of..
1/23/202417:31EDGAR2Form S-1 - General form for registration of securities under..
1/22/202408:00EDGAR2Form 8-K - Current report
1/22/202407:00GLOBESagimet Biosciences Announces Positive Topline Results from..
12/29/202316:16EDGAR2Form 8-K - Current report
12/08/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202308:00GLOBESagimet Biosciences to Participate in the First Annual..
11/28/202308:00GLOBESagimet Biosciences Announces Oral Presentation of..
11/22/202308:00GLOBESagimet Biosciences to Present at the 35th Annual Piper..
11/21/202316:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/21/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202321:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202308:40EDGAR2Form 8-K - Current report
11/13/202308:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202308:00GLOBESagimet Biosciences Reports Third Quarter 2023 Financial..
11/10/202308:30GLOBESagimet Biosciences Presents Preclinical Results Supporting..
10/24/202311:00GLOBESagimet Biosciences Announces Acceptance of Two Abstracts at..
10/23/202308:00EDGAR2Form 8-K - Current report
10/18/202316:05GLOBESagimet Biosciences To Present at the H.C. Wainwright 7th..
9/27/202316:32EDGAR2Form 8-K - Current report
9/27/202316:05GLOBESagimet Biosciences Announces Completion of Enrollment of..
9/08/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/21/202316:09EDGAR2Form 8-K - Current report
8/21/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/21/202316:02GLOBESagimet Biosciences Reports Second Quarter 2023 Financial..
8/15/202316:04GLOBESagimet Biosciences Announces Closing of Underwriters’..
8/10/202308:14EDGAR2Form 8-K - Current report
7/20/202316:05GLOBESagimet Biosciences Announces Leadership Changes
7/13/202321:10GLOBESagimet Biosciences Announces Pricing of Upsized Initial..
6/23/202302:30GLOBESagimet Biosciences Presents Positive Phase 2b FASCINATE-2..
6/07/202309:00GLOBESagimet Biosciences to Present Interim Data from Phase 2b..

Your Recent History

Delayed Upgrade Clock